Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01272284 · ClinicalTrials.gov registry record · NA

The Altis® Single Incision Sling System for Female Stress Urinary Incontinence Study

A NA study, sponsored by Coloplast A/S.

Completed
Registry status
NA
Development phase
113
Enrollment target

NCT01272284: Completed NA study, sponsored by Coloplast A/S.

NCT01272284 is a NA study that has completed, run by Coloplast A/S. The registered enrollment target is 113 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01272284, a NA study, has completed, sponsored by Coloplast A/S.

COMPLETED
Registry status
NA
Development phase
113 participants
Enrollment target

Study Summary

An international, multi-center, single arm, prospective clinical study designed to assess the safety and efficacy of the Coloplast Altis single incision sling system for females with stress urinary incontinence (SUI).

Primary Outcome

Primary endpoint defined as at least a 50% reduction in 24-hour pad weight from baseline to 6 months (including dry as defined as a pad weight of less than 1.3 grams during the 6-month test), in which the percent of subjects with at least 50% reduction in 24-hour pad weight is compared to a performance goal of 50%.

Interventions

  • DEVICE Altis® Single Incision Sling System (SIS)

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2010-12
Est. Completion 2014-01
Phase NA
Coloplast A/S

21 total trials

What the finished NCT01272284 record still lists

NCT01272284 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Altis® Single Incision Sling System (SIS) is the first listed.

NCT01272284 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01272284 about?

NCT01272284 is a clinical study titled "The Altis® Single Incision Sling System for Female Stress Urinary Incontinence Study". An international, multi-center, single arm, prospective clinical study designed to assess the safety and efficacy of the Coloplast Altis single incision sling system for females with stress urinary incontinence (SUI).

What is the current status of trial NCT01272284?

This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2010-12. Estimated completion is 2014-01.

What interventions are being tested in trial NCT01272284?

The interventions under investigation include: Altis® Single Incision Sling System (SIS) (DEVICE).

Who is sponsoring clinical trial NCT01272284?

This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01272284's enrollment target sits among peer trials

113 813th of 2000 higher than 1,188 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00748254 · 113 participants

    Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

  • NCT04753190 · 113 participants · NA

    Light Timing Study

  • NCT05799248 · 113 participants · Phase 3

    Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

  • NCT07216105 · 113 participants · Phase 1

    FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01272284, the US trial registry maintained by the National Library of Medicine. NCT01272284 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.